• 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Iranian journal of psychiatry. >Comparison of the Prevalence of Psychiatric Disorders in Performance-Enhancing Drug Users and Nonuser Bodybuilders
【24h】

Comparison of the Prevalence of Psychiatric Disorders in Performance-Enhancing Drug Users and Nonuser Bodybuilders

机译：增强性能的吸毒者和非使用者健美运动员中精神疾病患病率的比较

获取原文
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

Objective: The present study aimed at comparing the prevalence of major psychiatric disorders including major depressive disorder, bipolar disorder, schizophrenia, and generalized anxiety disorder between performance-enhancing drug users and nonuser bodybuilders. Moreover, the prevalence of major psychiatric disorders in bodybuilders was also reported.Method: In this study, 453 athletes were recruited from Bushehr bodybuilding gyms from February to May 2015. A structured questionnaire was used to collect the participants’ information, including demographic characteristics, sports’ status and performance-enhancing drug use. According to the condition of performance-enhancing drug use, the participants were divided into current users, non-current users, and nonusers. The psychiatric status of the participants was evaluated using DSM-IV diagnostic criteria for major depressive disorder, bipolar disorder, generalized anxiety disorder, and schizophrenia. We also asked about the acute psychotic disturbances after using performance-enhancing drugs, alcohol use, and history of aggressive behavior in bodybuilders. Data were analyzed using one-way analysis of variance and chi-square tests.Results: Prevalence of major depressive disorder, bipolar disorder, schizophrenia, generalized anxiety disorder, and the overall prevalence of psychiatric disorders in the bodybuilders was 19.7%, 3.8%, 1.5%, 16.6%, and 26.7%, respectively. After using performance-enhancing drugs, 33% of the bodybuilders had experienced acute psychological disturbances. There were no significant differences between current, non-current, and nonuser bodybuilding athletes in the measured psychiatric disorders.Conclusion: Prevalence of psychiatric disorders was not significantly different in performance-enhancing drug users and nonusers. Thus, it can be concluded that performance-enhancing drugs do not increase the risk of psychiatric disorders in bodybuilders.
机译：目的：本研究旨在比较提高性能的吸毒者和非吸毒者健美者之间的主要精神疾病（包括重度抑郁症，躁郁症，精神分裂症和广义焦虑症）的患病率。此外，还报告了健美运动员中主要精神疾病的患病率。方法：本研究从2015年2月至2015年5月从Bushehr健美体育馆招募了453名运动员。我们使用结构化问卷收集了参与者的信息，包括人口统计特征，运动的地位和提高成绩的药物使用情况。根据提高药物使用效果的条件，将参与者分为当前用户，非当前用户和非用户。使用DSM-IV诊断标准评估参与者的精神状态，以评估其主要的抑郁症，躁郁症，广泛性焦虑症和精神分裂症。我们还询问了使用性能增强药物后的急性精神疾病，饮酒情况以及健美运动员的攻击行为史。使用单因素方差分析和卡方检验对数据进行分析。结果：健美运动员的主要抑郁症，双相情感障碍，精神分裂症，广泛性焦虑症的患病率分别为19.7％，3.8％，分别为1.5％，16.6％和26.7％。使用增强性能的药物后，有33％的健美运动员遭受了严重的心理困扰。在测量的精神病患者中，现役，非现役和非使用者健美运动员之间无显着差异。结论：提高性能的吸毒者和非使用者的精神病患病率无显着差异。因此，可以得出结论，增强性能的药物不会增加健美运动员精神障碍​​的风险。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号